Lakefront Biotherapeutics NV (LKFT)
NMS · Healthcare · Biotechnology
$31.40
+2.68%
Closing price as of 2026-10-22 · Source: TEK2day Finance
Key Metrics
Market Cap
$2.06B
Shares Outstanding
65.5M
P/S (TTM)
1.8x
Exchange
NMS
Currency
USD
Quarterly Financials (EUR)
| Metric | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 71.2M | 900.8M | 6.5M | 12.1M |
| Gross Profit | 60.3M | 900.4M | 1.7M | 3.0M |
| Operating Income | (41.7M) | 758.8M | (63.7M) | (43.5M) |
| Net Income | (202.1M) | 782.1M | 14.5M | 2.1M |
| Diluted EPS | EUR 0.22 |
Annual Financials (EUR)
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 241.2M | 239.7M | 275.6M | 1.1B |
| Gross Profit | 241.2M | 239.7M | 240.8M | 1.1B |
| Operating Income | (131.1M) | (88.3M) | (188.3M) | 501.4M |
| Net Income | (218.0M) | 211.7M | 74.1M | 320.9M |
| Diluted EPS | (EUR 3.32) | EUR 3.21 | EUR 1.12 | EUR 4.87 |